Gestational diabetes screening: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==Overview== | ||
== 2013 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)<ref name="pmid23264422">{{cite journal| author=American Diabetes Association| title=Standards of medical care in diabetes--2013. | journal=Diabetes Care | year= 2013 | volume= 36 Suppl 1 | issue= | pages= S11-66 | pmid=23264422 | doi=10.2337/dc13-S011 | pmc=PMC3537269 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23264422 }} </ref>== | |||
===Screening for Gestational Diabetes (GDM)=== | |||
{|class="wikitable" | |||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''1.''' Screen for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''2.''' In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''3.''' Screen womenwithGDMfor persistent diabetes at 6–12 weeks postpartum, using the OGTT and nonpregnancy diagnostic criteria. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: E]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''4.''' Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 years. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''4.''' Women with a history of GDM found to have prediabetes should receive lifestyle interventions or [[metformin]] to prevent diabetes. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | |||
|- | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:36, 16 December 2013
|
Gestational diabetes Microchapters |
|
Complications |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gestational diabetes screening On the Web |
|
American Roentgen Ray Society Images of Gestational diabetes screening |
|
Risk calculators and risk factors for Gestational diabetes screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
2013 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)[1]
Screening for Gestational Diabetes (GDM)
| "1. Screen for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. (Level of Evidence: B)" |
| "2. In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. (Level of Evidence: B)" |
| "3. Screen womenwithGDMfor persistent diabetes at 6–12 weeks postpartum, using the OGTT and nonpregnancy diagnostic criteria. (Level of Evidence: E)" |
| "4. Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 years. (Level of Evidence: B)" |
| "4. Women with a history of GDM found to have prediabetes should receive lifestyle interventions or metformin to prevent diabetes. (Level of Evidence: A)" |
References
- ↑ American Diabetes Association (2013). "Standards of medical care in diabetes--2013". Diabetes Care. 36 Suppl 1: S11–66. doi:10.2337/dc13-S011. PMC 3537269. PMID 23264422.